NCT03276247 is a clinical trial of observation in Iron Metabolism Disorders, sponsored by Victor Gordeuk.

Who is sponsoring NCT03276247?

NCT03276247 is sponsored by Victor Gordeuk.

What drugs are being tested in NCT03276247?

Interventions in NCT03276247: observation.

What condition does NCT03276247 study?

NCT03276247 studies Iron Metabolism Disorders.

Is NCT03276247 still recruiting?

NCT03276247 is currently completed. Last updated 8 September 2017.

Last reviewed 2017-09-08 · How we verify

NCT03276247

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iron Status in Women of Reproductive Age Reproductive Age

Completed Last updated 8 September 2017

What this trial tests

trial testing observation in Iron Metabolism Disorders in 22,042 participants. Completed in 1 August 2017.

Timeline

1 January 2016

Primary endpoint
1 August 2017

1 August 2017

Quick facts

Lead sponsor	Victor Gordeuk
Status	Completed
Study type	OBSERVATIONAL
Enrollment	22,042
Start date	1 January 2016
Primary completion	1 August 2017
Estimated completion	1 August 2017
Sites	1 location across United States

Drugs / interventions tested

observation

Conditions studied

Iron Metabolism Disorders — all drugs for Iron Metabolism Disorders →

Sponsor

Victor Gordeuk

Who can join

Adults 25 to 44, female only, with Iron Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Analyzed iron status, HFE mutations and ethnicity for women in five primary care centers in the United States and Canada using de-identified data from the HEIRS study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ethnic and genetic factors of iron status in women of reproductive age.
Gordeuk VR, Brannon PM. · · 2017 · cited 18× · PMID 29070555 · DOI 10.3945/ajcn.117.155853

Verify or expand the search:

Other trials of observation

Trials testing the same drug.

NCT06493448 — Prospective Observational Cohort Study · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
NCT06327165 — Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension · unknown
NCT06114446 — The Evaluation of the Effectiveness of Nursing Care Education Provided With Immersive Virtual Reality · NA · completed

Other recruiting trials for Iron Metabolism Disorders

Currently open trials in the same condition.

NCT05586867 — Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in · recruiting
NCT04008147 — Hepcidin and Glucose Metabolism · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03276247 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Victor Gordeuk
Last refreshed: 8 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing